Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal.
about
Abiraterone Acetate: A Review in Metastatic Castration-Resistant Prostrate Cancer.Treatments for Metastatic Prostate Cancer (mPC): A Review of Costing Evidence.Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal".Comment on: "Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal".
P2860
Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Abiraterone Acetate for the Tr ...... E Single Technology Appraisal.
@ast
Abiraterone Acetate for the Tr ...... E Single Technology Appraisal.
@en
type
label
Abiraterone Acetate for the Tr ...... E Single Technology Appraisal.
@ast
Abiraterone Acetate for the Tr ...... E Single Technology Appraisal.
@en
prefLabel
Abiraterone Acetate for the Tr ...... E Single Technology Appraisal.
@ast
Abiraterone Acetate for the Tr ...... E Single Technology Appraisal.
@en
P2093
P2860
P50
P921
P1433
P1476
Abiraterone Acetate for the Tr ...... E Single Technology Appraisal.
@en
P2093
Johan L Severens
Jos Kleijnen
Nigel Armstrong
Rob Riemsma
Sohan Deshpande
Steven Duffy
P2860
P2888
P304
P356
10.1007/S40273-016-0445-5
P5008
P577
2016-08-26T00:00:00Z
2017-02-01T00:00:00Z